In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Danaher pays $352mm for urinalysis firm IRIS International

Executive Summary

Medical and industrial products manufacturer Danaher Corp. is acquiring publicly traded IRIS International Inc. (body fluid analysis, sample processing, and early disease detection) for $352mm, or $19.50 per share (a 51% premium).
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Laboratory Testing Services
  • Medical Devices
  • Services
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Hematology, Coagulation
    • Molecular Diagnostics & Genetic Testing
    • Urine-based Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register